Bristol-Myers Squibb Company (NYSE:BMY) Q4 2022 Earnings Call Transcript
Operator: Good morning. My name is Dennis, and I will be your conference operator today.
Source: insidermonkey.com
Stay updated with breaking news from Robert Plenge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good morning. My name is Dennis, and I will be your conference operator today.
BMY earnings call for the period ending December 31, 2022.
GentiBio and BMS have signed a partnership agreement for developing new engineered Treg therapies for inflammatory bowel disease patients.
/PRNewswire/ -- GentiBio, Inc., an engineered regulatory T cells (Tregs) company, announced today that it has entered into a collaboration with Bristol Myers...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!